Literature DB >> 30720465

β Cell tone is defined by proglucagon peptides through cAMP signaling.

Megan E Capozzi1, Berit Svendsen1, Sara E Encisco1, Sophie L Lewandowski2, Mackenzie D Martin1, Haopeng Lin3, Justin L Jaffe1, Reilly W Coch1,4, Jonathan M Haldeman1,5, Patrick E MacDonald3, Matthew J Merrins2, David A D'Alessio1,4, Jonathan E Campbell1,4,5.   

Abstract

Paracrine interactions between pancreatic islet cells have been proposed as a mechanism to regulate hormone secretion and glucose homeostasis. Here, we demonstrate the importance of proglucagon-derived peptides (PGDPs) for α to β cell communication and control of insulin secretion. Signaling through this system occurs through both the glucagon-like peptide receptor (Glp1r) and glucagon receptor (Gcgr). Loss of PGDPs, or blockade of their receptors, decreases insulin secretion in response to both metabolic and nonmetabolic stimulation of mouse and human islets. This effect is due to reduced β cell cAMP and affects the quantity but not dynamics of insulin release, indicating that PGDPs dictate the magnitude of insulin output in an isolated islet. In healthy mice, additional factors that stimulate cAMP can compensate for loss of PGDP signaling; however, input from α cells is essential to maintain glucose tolerance during the metabolic stress induced by high-fat feeding. These findings demonstrate an essential role for α cell regulation of β cells, raising the possibility that abnormal paracrine signaling contributes to impaired insulin secretion in diabetes. Moreover, these findings support reconsideration of the role for α cells in postprandial glucose control.

Entities:  

Keywords:  Endocrinology; G-protein coupled receptors; Insulin; Islet cells; Metabolism

Mesh:

Substances:

Year:  2019        PMID: 30720465      PMCID: PMC6483521          DOI: 10.1172/jci.insight.126742

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  54 in total

1.  Glucagon receptors on human islet cells contribute to glucose competence of insulin release.

Authors:  P Huypens; Z Ling; D Pipeleers; F Schuit
Journal:  Diabetologia       Date:  2000-08       Impact factor: 10.122

2.  Stimulation by glucagon of insulin release from rabbit pancreas in vitro.

Authors:  D S Turner; N McIntyre
Journal:  Lancet       Date:  1966-02-12       Impact factor: 79.321

3.  Interrupted Glucagon Signaling Reveals Hepatic α Cell Axis and Role for L-Glutamine in α Cell Proliferation.

Authors:  E Danielle Dean; Mingyu Li; Nripesh Prasad; Scott N Wisniewski; Alison Von Deylen; Jason Spaeth; Lisette Maddison; Anthony Botros; Leslie R Sedgeman; Nadejda Bozadjieva; Olga Ilkayeva; Anastasia Coldren; Greg Poffenberger; Alena Shostak; Michael C Semich; Kristie I Aamodt; Neil Phillips; Hai Yan; Ernesto Bernal-Mizrachi; Jackie D Corbin; Kasey C Vickers; Shawn E Levy; Chunhua Dai; Christopher Newgard; Wei Gu; Roland Stein; Wenbiao Chen; Alvin C Powers
Journal:  Cell Metab       Date:  2017-06-06       Impact factor: 27.287

4.  Nutrient control of insulin secretion in isolated normal human islets.

Authors:  Jean-Claude Henquin; Denis Dufrane; Myriam Nenquin
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

5.  Interplay of nutrients and hormones in the regulation of insulin release.

Authors:  D G Pipeleers; F C Schuit; P A in't Veld; E Maes; E L Hooghe-Peters; M Van de Winkel; W Gepts
Journal:  Endocrinology       Date:  1985-09       Impact factor: 4.736

6.  Regulation of adenosine 3',5'-monophosphate levels in the pancreatic B cell.

Authors:  F C Schuit; D G Pipeleers
Journal:  Endocrinology       Date:  1985-09       Impact factor: 4.736

7.  Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas.

Authors:  J E Gerich; M A Charles; G M Grodsky
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

8.  Phenotypic Characterization of MIP-CreERT1Lphi Mice With Transgene-Driven Islet Expression of Human Growth Hormone.

Authors:  Daniel Oropeza; Nathalie Jouvet; Lionel Budry; Jonathan E Campbell; Khalil Bouyakdan; Julie Lacombe; Gabrielle Perron; Valerie Bergeron; Joshua C Neuman; Harpreet K Brar; Rachel J Fenske; Clemence Meunier; Sarah Sczelecki; Michelle E Kimple; Daniel J Drucker; Robert A Screaton; Vincent Poitout; Mathieu Ferron; Thierry Alquier; Jennifer L Estall
Journal:  Diabetes       Date:  2015-07-07       Impact factor: 9.461

9.  Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor.

Authors:  Jonathan D Douros; Alfor G Lewis; Eric P Smith; JingJing Niu; Megan Capozzi; April Wittmann; Jonathan Campbell; Jenny Tong; Constance Wagner; Parinaz Mahbod; Randy Seeley; David A D'Alessio
Journal:  Diabetes       Date:  2018-05-14       Impact factor: 9.461

Review 10.  The somatostatin-secreting pancreatic δ-cell in health and disease.

Authors:  Patrik Rorsman; Mark O Huising
Journal:  Nat Rev Endocrinol       Date:  2018-07       Impact factor: 43.330

View more
  69 in total

1.  Discordance between GLP-1R gene and protein expression in mouse pancreatic islet cells.

Authors:  Sarah M Gray; Yurong Xin; Elizabeth C Ross; Bryanna M Chazotte; Megan E Capozzi; Kimberley El; Berit Svendsen; Peter Ravn; Kyle W Sloop; Jenny Tong; Jesper Gromada; Jonathan E Campbell; David A D'Alessio
Journal:  J Biol Chem       Date:  2020-06-18       Impact factor: 5.157

Review 2.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

3.  Glycemic effect of pancreatic preproglucagon in mouse sleeve gastrectomy.

Authors:  Ki-Suk Kim; Chelsea R Hutch; Landon Wood; Irwin J Magrisso; Randy J Seeley; Darleen A Sandoval
Journal:  JCI Insight       Date:  2019-10-17

4.  The Limited Role of Glucagon for Ketogenesis During Fasting or in Response to SGLT2 Inhibition.

Authors:  Megan E Capozzi; Reilly W Coch; Jepchumba Koech; Inna I Astapova; Jacob B Wait; Sara E Encisco; Jonathan D Douros; Kimberly El; Brian Finan; Kyle W Sloop; Mark A Herman; David A D'Alessio; Jonathan E Campbell
Journal:  Diabetes       Date:  2020-01-31       Impact factor: 9.461

5.  The role of GIP and pancreatic GLP-1 in the glucoregulatory effect of DPP-4 inhibition in mice.

Authors:  Chelsea R Hutch; Karen Roelofs; April Haller; Joyce Sorrell; Kyle Leix; David D D'Alessio; Robert Augustin; Randy J Seeley; Thomas Klein; Darleen A Sandoval
Journal:  Diabetologia       Date:  2019-08-14       Impact factor: 10.122

6.  Glucagon lowers glycemia when β-cells are active.

Authors:  Megan E Capozzi; Jacob B Wait; Jepchumba Koech; Andrew N Gordon; Reilly W Coch; Berit Svendsen; Brian Finan; David A D'Alessio; Jonathan E Campbell
Journal:  JCI Insight       Date:  2019-07-23

7.  Intra-islet glucagon signaling is critical for maintaining glucose homeostasis.

Authors:  Lu Zhu; Diptadip Dattaroy; Jonathan Pham; Lingdi Wang; Luiz F Barella; Yinghong Cui; Kenneth J Wilkins; Bryan L Roth; Ute Hochgeschwender; Franz M Matschinsky; Klaus H Kaestner; Nicolai M Doliba; Jürgen Wess
Journal:  JCI Insight       Date:  2019-04-23

8.  Updating the Role of α-Cell Preproglucagon Products on GLP-1 Receptor-Mediated Insulin Secretion.

Authors:  Darleen Sandoval
Journal:  Diabetes       Date:  2020-11       Impact factor: 9.461

Review 9.  Leveraging the Gut to Treat Metabolic Disease.

Authors:  Ruth E Gimeno; Daniel A Briere; Randy J Seeley
Journal:  Cell Metab       Date:  2020-03-17       Impact factor: 27.287

Review 10.  The role of GIP in α-cells and glucagon secretion.

Authors:  Kimberley El; Jonathan E Campbell
Journal:  Peptides       Date:  2019-11-27       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.